Valuation: Zai Lab Limited

Market Cap 2.77B 21.7B 2.51B 2.32B 2.09B 3.94B 261B 4.08B 27.85B 11.04B 139B 10.38B 10.16B 442B P/E 2026 *
-13.2x
P/E 2027 * -11.5x
Enterprise Value 2.13B 16.69B 1.93B 1.78B 1.61B 3.03B 201B 3.14B 21.42B 8.49B 107B 7.98B 7.81B 340B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.26x
Free-Float
93.88%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Zai Lab Limited

1 day-3.71%
1 week+10.24%
Current month+16.52%
1 month+15.79%
3 months+0.70%
6 months+31.86%
Current year+48.28%
1 week 19.89
Extreme 19.89
21.5
1 month 16.57
Extreme 16.57
21.5
Current year 12.31
Extreme 12.31
21.5
1 year 12.31
Extreme 12.31
21.5
3 years 10.56
Extreme 10.56
35.5
5 years 10.56
Extreme 10.56
72
10 years 10.56
Extreme 10.56
151.2
Manager TitleAgeSince
Chief Executive Officer 61 2014-03-31
Director of Finance/CFO 58 2023-07-06
President 62 2022-11-30
Director TitleAgeSince
Chairman 61 2014-03-31
Director/Board Member 83 2016-12-31
Director/Board Member 75 2016-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-3.71%+10.24% - - 2.77B
+1.26%+6.61%+40.79%+136.32% 1,286B
+0.79%+3.45%+45.84%+93.52% 688B
+0.20%+1.28%+26.97%+113.70% 521B
-0.44%+3.69%+41.45%+68.91% 386B
+0.55%+0.70%+59.02%+44.62% 364B
-0.12%+0.74%+28.39%+58.54% 302B
+0.37%+0.37%+3.33%+37.27% 287B
-0.30%+1.14%+38.29%+72.46% 252B
+0.08%+0.71%+34.44%+124.95% 208B
Average -0.13%+2.08%+35.39%+83.36% 477B
Weighted average by Cap. +0.54%+3.26%+37.70%+96.50%

Financials

2026 *2027 *
Net sales 439M 3.45B 398M 368M 332M 626M 41.41B 648M 4.42B 1.75B 22.12B 1.65B 1.61B 70.21B 538M 4.22B 487M 451M 407M 766M 50.68B 793M 5.41B 2.15B 27.07B 2.02B 1.97B 85.94B
Net income -213M -1.67B -193M -179M -161M -304M -20.13B -315M -2.15B -852M -10.75B -801M -784M -34.13B -218M -1.71B -198M -183M -165M -311M -20.57B -322M -2.2B -871M -10.99B -819M -801M -34.88B
Net Debt -639M -5.01B -579M -535M -483M -910M -60.22B -942M -6.43B -2.55B -32.17B -2.4B -2.35B -102B -474M -3.72B -429M -397M -358M -675M -44.68B -699M -4.77B -1.89B -23.87B -1.78B -1.74B -75.76B
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
26-11-13 HK$20.24 -3.71% 3,443,000
26-11-12 HK$21.02 +2.74% 4,826,400
26-11-11 HK$20.46 -4.75% 4,265,500
26-11-10 HK$21.48 +2.48% 7,042,800
26-11-09 HK$20.96 +14.16% 10,226,265
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
24.60USD
Average target price
34.12USD
Spread / Average Target
+38.72%